Version 5.4
Bos taurus Protein: BT.45215
Summary
InnateDB Protein IDBP-698233.2
Last Modified 2014-10-13 [Report errors or provide feedback]
Gene Symbol BT.45215
Protein Name patatin-like phospholipase domain-containing protein 2
Synonyms ATGL;
Species Bos taurus
Ensembl Protein ENSBTAP00000029866
InnateDB Gene IDBG-645523 (BT.45215)
Protein Structure
UniProt Annotation
Function
Subcellular Localization
Disease Associations
Tissue Specificity
Comments
Interactions
Number of Interactions This gene and/or its encoded proteins are associated with 0 experimentally validated interaction(s) in this database.
They are also associated with 4 interaction(s) predicted by orthology.
Predicted by orthology
Total 4 [view]
Gene Ontology

Molecular Function
Accession GO Term
GO:0004806 triglyceride lipase activity
GO:0005515 protein binding
Biological Process
GO:0006629 lipid metabolic process
GO:0008152 metabolic process
GO:0010891 negative regulation of sequestering of triglyceride
GO:0010898 positive regulation of triglyceride catabolic process
GO:0019915 lipid storage
GO:0034389 lipid particle organization
Cellular Component
GO:0005811 lipid particle
GO:0005829 cytosol
GO:0043231 intracellular membrane-bounded organelle
Protein Structure and Domains
PDB ID
InterPro IPR002641 Patatin/Phospholipase A2-related
IPR016035 Acyl transferase/acyl hydrolase/lysophospholipase
PFAM PF01734
PRINTS
PIRSF
SMART
TIGRFAMs
Post-translational Modifications
Modification
Cross-References
SwissProt
PhosphoSite PhosphoSite-
TrEMBL G5E5T0
UniProt Splice Variant
Entrez Gene 508493
UniGene Bt.107056
RefSeq NP_001039470
HUGO HGNC:30802
OMIM
CCDS
HPRD
IMGT
EMBL DAAA02063755
GenPept

If you use InnateDB for your research, please cite the following publication:

Breuer et al., InnateDB: systems biology of innate immunity and beyond - recent updates and continuing curation. Nucl. Acids Res. (2013) 41 (D1) 

InnateDB is being developed jointly by the Brinkman Laboratory (Simon Fraser University, British Columbia, Canada), the Hancock Laboratory (University of British Columbia, Vancouver, British Columbia) and the Lynn EMBL Australia Group (South Australian Health & Medical Research Institute and Flinders University, Adelaide, Australia).

Funding is currently provided by Allergen and EMBL Australia. Previous funding has been provided by Genome Canada, the Foundation for the National Institutes of Health through the Grand Challenges in Global Health initiative and by Teagasc. InnateDB curated interactions are licensed under the Design Science License. All other data is licensed under the terms of the originating database. Contact: innatedb-mail@sfu.ca